{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:09:49Z","timestamp":1790514589142,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jad-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jad.2015.07.040","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T22:44:38Z","timestamp":1440197078000},"page":"101-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Correlates of benzodiazepine use in major depressive disorder: The effect of anhedonia"],"prefix":"10.1016","volume":"187","author":[{"given":"Sakina J.","family":"Rizvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Sproule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gallaugher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney H.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2015.07.040_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2015.07.040_bib3","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: prospective population based study","volume":"345","author":"Billioti de Gage","year":"2012","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jad.2015.07.040_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00508636","article-title":"The effect of intraperitoneally administered GABA on brain monoamine metabolism","volume":"299","author":"Biswas","year":"1977","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.jad.2015.07.040_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.eurpsy.2012.09.001","article-title":"Interactions between transcranial direct current stimulation (tDCS) and pharmacological interventions in the Major Depressive Episode: findings from a naturalistic study","volume":"28","author":"Brunoni","year":"2013","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archpsyc.1993.01820240059008","article-title":"A psychological model of temperament and character","volume":"50","author":"Cloninger","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib7","series-title":"NEO Personality Inventory Professional Manual","author":"Costa","year":"1992"},{"issue":"Suppl E1","key":"10.1016\/j.jad.2015.07.040_bib8","doi-asserted-by":"crossref","first-page":"e04","DOI":"10.4088\/JCP.9058se1c.04gry","article-title":"Major depressive disorder treatment guidelines in America and Europe","volume":"71","author":"Davidson","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00124509-200106000-00006","article-title":"Characteristics of responders and nonresponders to brief-pulse right unilateral ECT in a controlled clinical trial","volume":"17","author":"Delva","year":"2001","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2015.07.040_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jad.2008.01.011","article-title":"Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD)","volume":"110","author":"Demyttenaere","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.07.040_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tins.2011.11.005","article-title":"The neurobiology of anhedonia and other reward-related deficits","volume":"35","author":"Der-Avakian","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jad.2015.07.040_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biopsych.2013.10.026","article-title":"Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression","volume":"76","author":"Downar","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2015.07.040_bib13","first-page":"13","article-title":"Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects","volume":"33","author":"Endicott","year":"1997","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2015.07.040_bib14","first-page":"321","article-title":"Quality of life enjoyment and satisfaction questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2015.07.040_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1017\/S1121189X00000531","article-title":"Patterns of benzodiazepine use in a Canadian population sample","volume":"18","author":"Esposito","year":"2009","journal-title":"Epidemiol. Psichiatr. Soc."},{"key":"10.1016\/j.jad.2015.07.040_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0091-3057(01)00507-X","article-title":"Pharmacodynamic and receptor binding changes during chronic lorazepam administration","volume":"69","author":"Fahey","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2015.07.040_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archgenpsychiatry.2011.131","article-title":"Anterior cingulate cortex \u03b3-aminobutyric acid in depressed adolescents: relationship to anhedonia","volume":"69","author":"Gabbay","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/308074a0","article-title":"Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity","volume":"308","author":"Gallager","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jad.2015.07.040_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1027\/1614-0001.26.3.132","article-title":"Is openness to experience an independent personality dimension?","volume":"26","author":"Garc\u00eda","year":"2005","journal-title":"J. Indiv. Differ."},{"key":"10.1016\/j.jad.2015.07.040_bib20","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1176\/ajp.138.8.1098","article-title":"CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa","volume":"138","author":"Gerner","year":"1981","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archpsyc.64.2.193","article-title":"Reduced prefrontal glutamate\/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy","volume":"64","author":"Hasler","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2012.01.003","article-title":"Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003\u20132010","volume":"124","author":"Hawkins","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"Suppl E1","key":"10.1016\/j.jad.2015.07.040_bib24","doi-asserted-by":"crossref","first-page":"e05","DOI":"10.4088\/JCP.9058se1c.05gry","article-title":"Major depressive disorder treatment guidelines in Japan","volume":"71","author":"Higuchi","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib25","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1176\/ajp.2007.164.5.778","article-title":"Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial","volume":"164","author":"Kennedy","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib26","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/hbm.20801","article-title":"Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies","volume":"30","author":"Koolschijn","year":"2009","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jad.2015.07.040_bib27","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0006-3223(02)01788-2","article-title":"Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT","volume":"54","author":"Kugaya","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib28","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited\u2014will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.jad.2015.07.040_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2710.2010.01213.x","article-title":"The use of benzodiazepine monotherapy for major depression before and after implementation of guidelines for benzodiazepine use","volume":"36","author":"Lai","year":"2011","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.jad.2015.07.040_bib30","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2146\/ajhp090611","article-title":"Influence of medications and diagnoses on fall risk in psychiatric inpatients","volume":"67","author":"Lavsa","year":"2010","journal-title":"Am J Health Syst Pharm."},{"key":"10.1016\/j.jad.2015.07.040_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1037\/0021-843X.104.1.132","article-title":"Reports of the childhood home environment in early-onset dysthymia and episodic major depression","volume":"104","author":"Lizardi","year":"1995","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.jad.2015.07.040_bib32","first-page":"167","article-title":"Self-report assessment of anxiety: somatic, cognitive, and behavioral modalities","volume":"4","author":"Lehrer","year":"1982","journal-title":"J. Behav. Assess."},{"key":"10.1016\/j.jad.2015.07.040_bib33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/NMD.0b013e3181e9daf7","article-title":"Use of benzodiazepines, hypnotics, and anxiolytics in major depressive disorder: association with chronic pain diseases","volume":"198","author":"Liu","year":"2010","journal-title":"J. Nerv. Ment. Dis."},{"issue":"4","key":"10.1016\/j.jad.2015.07.040_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/mp.2010.120","article-title":"The GABAergic deficit hypothesis of major depressive disorder","volume":"16","author":"Luscher","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"Suppl 433","key":"10.1016\/j.jad.2015.07.040_bib35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0447.2007.00969.x","article-title":"Does dopamine dysfunction drive depression?","volume":"115","author":"Malhi","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2015.07.040_bib36","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/JCP.0b013e3182362484","article-title":"Determinants of initiated and continued benzodiazepine use in the Netherlands study of depression and anxiety","volume":"31","author":"Manthey","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.07.040_bib37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/ajp.156.5.675","article-title":"Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness","volume":"156","author":"Mayberg","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib38","first-page":"12","article-title":"Attention-deficit\/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative project","author":"McIntyre","year":"2010","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaac.2012.01.011","article-title":"Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression","volume":"51","author":"McMakin","year":"2012","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib40","first-page":"167","article-title":"Chronic benzodiazepine administration: effects in vivo and in vitro","volume":"46","author":"Miller","year":"1990","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.07.040_bib41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib42","first-page":"470985","article-title":"Predictors of time to relapse\/recurrence after electroconvulsive therapy in patients with major depressive disorder: a population-based cohort study","volume":"2011","author":"Nordenskj\u00f6ld","year":"2011","journal-title":"Depression Res. Treat."},{"key":"10.1016\/j.jad.2015.07.040_bib43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/070674371005501207","article-title":"Pharmacoepidemiology of benzodiazepine and sedative-hypnotic use in a Canadian general population cohort during 12 years of follow-up","volume":"55","author":"Patten","year":"2010","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0006-3223(92)90039-3","article-title":"Low plasma gamma-aminobutyric acid levels in male patients with depression","volume":"32","author":"Petty","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/070674371105600606","article-title":"Pattern of psychotropic drug use among older adults having a depression or an anxiety disorder: results from the longitudinal ESA study","volume":"56","author":"Pr\u00e9ville","year":"2011","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib47","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopsych.2008.10.025","article-title":"Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder","volume":"65","author":"Price","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/070674371405900702","article-title":"Treatment resistant depression in primary care across Canada: results from the insight study","volume":"59","author":"Rizvi","year":"2014","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib49","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archpsyc.56.11.1043","article-title":"Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy","volume":"56","author":"Sanacora","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/070674371105601105","article-title":"The utilization of antidepressants and benzodiazepines among people with major depression in Canada","volume":"56","author":"Sanyal","year":"2011","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib51","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1192\/bjp.187.5.462","article-title":"Adherence to guidelines for treatment of depression in in-patients","volume":"187","author":"Schneider","year":"2005","journal-title":"Br. J. Psychiatry"},{"issue":"Suppl 3","key":"10.1016\/j.jad.2015.07.040_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-199606003-00015","article-title":"The measurement of disability","volume":"11","author":"Sheehan","year":"1996","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"Suppl 20","key":"10.1016\/j.jad.2015.07.040_bib53","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib54","doi-asserted-by":"crossref","first-page":"e71964","DOI":"10.1371\/journal.pone.0071964","article-title":"Low openness on the revised NEO personality inventory as a risk factor for treatment-resistant depression","volume":"8","author":"Takahashi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2015.07.040_bib55","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neubiorev.2010.06.006","article-title":"Reconsidering anhedonia in depression: lessons from translational neuroscience","volume":"35","author":"Treadway","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2015.07.040_bib56","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S0033291707001730","article-title":"Measuring depression: comparison and integration of three scales in the GENDEP study","volume":"38","author":"Uher","year":"2008","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2015.07.040_bib57","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1017\/S0033291711001905","article-title":"Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms","volume":"42","author":"Uher","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2015.07.040_bib58","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1176\/appi.ajp.161.4.654","article-title":"Benzodiazepine use among depressed patients treated in mental health settings","volume":"161","author":"Valenstein","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.07.040_bib59","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.neuron.2012.02.016","article-title":"Activation of VTA GABA neurons disrupts reward consumption","volume":"73","author":"van Zessen","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.jad.2015.07.040_bib60","series-title":"WHO Collaborating Centre for Drug Statistics Methodology","author":"World Health Organization","year":"1997"},{"issue":"Suppl E1","key":"10.1016\/j.jad.2015.07.040_bib61","doi-asserted-by":"crossref","first-page":"e06","DOI":"10.4088\/JCP.9058se1c.06gry","article-title":"Major depressive disorder treatment guidelines in China","volume":"71","author":"Zhang","year":"2010","journal-title":"J. Clin. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715303001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715303001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T09:48:25Z","timestamp":1691920105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032715303001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":60,"alternative-id":["S0165032715303001"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2015.07.040","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlates of benzodiazepine use in major depressive disorder: The effect of anhedonia","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2015.07.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}